Rapid rescreening of cervical smears as a quality control method in a high-risk population

Cytopathology

Volumn 17, Issue 3, 2006, Pages 110-115

  Michelow, P ^a   McKee, G ^a   Hlongwane, F ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Cervical carcinoma screening; Cervical cytology; Quality assurance; Rapid review

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CYTOTECHNOLOGIST; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUALITY CONTROL; RESCREENING; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; SQUAMOUS EPITHELIUM; STATISTICAL SIGNIFICANCE; TUMOR BIOPSY; UTERINE CERVIX CYTOLOGY;

CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; QUALITY CONTROL; RISK-TAKING; SOUTH AFRICA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 33744737612     PISSN: 09565507     EISSN: 13652303     Source Type: Journal    
DOI: 10.1111/j.1365-2303.2006.00366.x     Document Type: Article

References (30)

1. Mqoqi N, Kellet P, Sitas F, Jula M. Incidence of Histologically Diagnosed Cancer in South Africa, 1998-1999. Johannesburg : National Cancer Registry, National Health Laboratory Service 2004.
2. IARC Working Group on Evaluation of Cervical Cancer Screening Programmes. Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policy. Br Med J 1986 293 : 659 64.
3. Koss L. The Papanicolaou test for cervical cancer detection. A triumph and a tragedy. JAMA 1989 261 : 737 43.
4. Council on Scientific Affairs. Quality assurance in cervical cytology. The Papanicolaou smear. JAMA 1989 262 : 1672 9.
5. American Society of Cytopathology. Cervical cytology practice guidelines. Diagn Cytopathol 2000 25 : 3 21.
6. De May R. Common problems in Papanicolaou smear interpretation. Arch Pathol Lab Med 1997 121 : 229 38.
7. Krieger P. Strategies for reducing Papanicolaou smear screening errors. Principles derived from data and experience with quality control. Arch Pathol Lab Med 1997 121 : 277 81.
8. Baker A, Melcher H. Rapid cervical cytology screening. Cytopathology 1991 2 : 299 301.
9. Solomon D, Nayar R. The Bethesda System for Reporting Cervical Cytology, 2nd edn. New York : Springer-Verlag 2004.
10. Johnson S, Hair T, Gibson L, Ridley B, Wahehra V. An assessment of partial rescreening as an internal quality control method for cervical smears. Cytopathology 1995 6 : 376 87.
11. Laara E, Day N, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: association with organized screening programmes. Lancet 1987 1 : 1247 9.
12. MacGregor J, Moss S, Parkin D, Day N. Cervical cancer screening in North East Scotland. In : Hakama M, Miller AB, Day NE, eds. Screening for Cancer of the Uterine Cervix. Lyon : IARC 1986 25 41.
13. Miller A, Lindsay J, Hill G. Mortality from cancer of the uterus in Canada and its relationship to screening for cancer of the cervix. Int J Cancer 1976 17 : 602 12.
14. Boyes D. The value of a pap smear program and suggestions for its implementation. Cancer 1981 48 : 613 21.
15. Aristizabal N, Cuello C, Correa P. The impact of vaginal cytology on cervical cancer risks in Cali, Columbia. Int J Cancer 1984 34 : 5 9.
16. Lazcano-Ponce E, Rascon-Paceco R, Lozano-Ascencio R, Velasco-Mondragon H. Mortality from cervical carcinoma in Mexico: impact of screening, 1980-1990. Acta Cytol 1996 40 : 506 12.
17. Lascano-Ponce E, Buiatti E, Najera-Aguilar P, Alonso-de-Ruiz P, Hernandez-Avila M. Evaluation model of the Mexican national program for early cervical cancer detection and proposals for a new approach. Cancer Causes Control 1998 9 : 241 51.
18. Kobilkova J, Pazdernik B, Duskova J. Incidence of cervical carcinoma in the Czech Republic. Acta Cytol 2001 45 : 515 8.
19. Editorial: Cancer of the cervix: death by incompetence. Lancet 1985 2 : 363 4.
20. Murphy M, Campbell M, Goldblatt P. Twenty years' screening for cancer of the uterine cervix in Great Britain, 1964-1984: further evidence for its ineffectiveness. J Epidemiol Community Health 1987 42 : 49 53.
21. Arbyn M, Schenck U, Ellison E, Hanselaar A. Metaanalysis of the accuracy of rapid prescreening relative to full rescreening of pap smears. Cancer (Cancer Cytopathology) 2003 99 : 9 16.
22. Cross P. Rapid rescreening of cervical smears as a quality control method. Cytopathology 1997 8 : 79 84.
23. Dudding N, Hewer E, Lancucki L, Rice S. Rapid screening: a comparative study. Cytopathology 2001 12 : 235 48.
24. Johnson S, Hair T, Gibson L, Ridley B, Wadehra V. An assessment of partial rescreening as an internal quality control method for cervical smears. Cytopathology 1995 6 : 376 87.
25. Brooke D, Dudding N, Sutton J. Rapid (partial) prescreening of cervical smears: the quality control method of choice? Cytopathology 2002 13 : 191 9.
26. Diehl A, Proller J. Rapid rescreening of cervical smears for internal quality control. Acta Cytol 1998 42 : 949 53.
27. Faraker C. Partial rescreening of all negative smears: an improved method of quality assurance in laboratories undertaking cervical screening. Cytopathology 1993 4 : 47 50.
28. Editorial: Assessing the costs and benefits of alternative rescreening strategies. Acta Cytol 1996 40 : 4 8.
29. Michelow P, Wright C, Mayet N. Evaluation of the interim cervical screening programme in the Greater Johannesburg Metropolitan area. S Afr J Epidemiol Infect 1999 14 : 36 9.
30. Renshaw A. Déjà vu in pap testing: return of the 5% false negative fraction and the zero-error rate. Diagn Cytopathol 2002 26 : 343 4 (editorial).